Seattle WA 白血病临床试验
12项针对 白血病的研究正在 Seattle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
招募中2 期
- Seattle Childrens Hospital, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
招募中观察性研究欢迎健康志愿者
- Seattle Children s Hospital, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中2 期
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
招募中观察性研究
- Seattle Children's Hospital, Seattle
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- Seattle Cancer Care Alliance, Seattle
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- University of Washington, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
招募中1/2 期
- Dren Investigational Site, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
招募中1 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Seattle Children's Hospital, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Seattle
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 白血病试验
- Houston, TX31 项研究
- Boston, MA27 项研究
- New York City, NY21 项研究
- Chicago, IL19 项研究
- Los Angeles, CA17 项研究
- Durham, NC14 项研究
- Baldwin Park, CA14 项研究
- Nashville, TN13 项研究
- Columbus, OH13 项研究
- Philadelphia, PA13 项研究
- Atlanta, GA12 项研究
- Milwaukee, WI12 项研究
Seattle的其他研究
- 非小细胞肺癌55 项研究
- 癌症（所有类型）48 项研究
- 前列腺癌45 项研究
- 急性髓系白血病40 项研究
- 转移性癌症39 项研究
- 乳腺癌37 项研究
- 结直肠癌35 项研究
- 肺癌34 项研究
- 卵巢癌29 项研究
- 胰腺癌22 项研究
- 多发性骨髓瘤22 项研究
- 急性淋巴细胞白血病22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。